Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats

Endocrinology

Volumn 137, Issue 5, 1996, Pages 1913-1920

  Fielder, Paul J ^a   Mortensen, Deborah L ^a   Mallet, Phyllis ^a   Carlsson, Bjorn ^b   Baxter, Robert C ^c   Clark, Ross G ^a  

^a GENENTECH INC   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CONTROLLED STUDY; FEMALE; GROWTH REGULATION; GROWTH STIMULATION; HORMONE PROTEIN COMPLEX; HYPOPHYSECTOMY; LONG TERM EXPOSURE; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

EID: 0029863848     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.5.8612531     Document Type: Article

References (41)

1. Zapf J, Hunziker EB 1994 The somatomedin hypothesis revisited: differential effects of growth hormone and IGF-I in the rat in vivo. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-Like Ggrowth Factors and their Regulatory Proteins. Excerpta Medica, Amsterdam, pp 381-392
2. Daughaday WH 1989 A personal history of the origin of the somatomedin hypothesis and recent challenges to its validity. Perspect Biol Med 32:194-211
3. Guler H-P, Zapf J, Scheiwiller E, Froesch ER 1988 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci 85:4889-4893
4. Skottner A, Clark RC, Robinson ICAF, Fryklund L 1986 Recombinant human insulin-like growth factor: testing the somatomedin hypothesis in hypophysectomized rats. J Endocrinol 112:123-132
5. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J 1987 Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8:426-438
6. Clark RG, Carlsson LMS, Mortensen D, Cronin MJ 1994 Additive effects on body growth of insulin-like growth factor-I and growth hormone in hypophysectomized rats. Endocrinol Metab 1:49-54
7. Clark RG, Mortensen D, Carlsson LMS 1995 Insulin-like growth factor-I and growth hormone have distinct and overlapping anabolic effects in GH-deficient rats. Endocrine 3:297-304
8. Hazel SJ, Gillespie CM, Moore RJ, Clark RG, Jureidini KF, Martin AA 1994 Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 46:58-68
9. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR 1993 Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 91:391-396
10. Walker JL, Baxter RC, Young S, Pucilowska J, Clemmons DR, Underwood LE 1993 Effects of recombinant Insulin-like growth factor I on IGF binding proteins and the acid-labile subunit in growth hormone insensitivity syndrome. Growth Regul 3:107-110
11. Rosenfield RG, Guevara-Aguirre J, Gargosky SE, Rosenbloom AL 1994 IGF-I treatment of syndromes of growth hormone insensitivity. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-Like Growth Factors and Their Regulatory Proteins. Excerpta Medica, Amsterdam, pp 357-464
12. Chen SA, Bukar JG, Molher MA, Cook J, Lewis D, Hatton J, Young AB, Rapp RP, Kudsk KA, Gesundheit N, Recombinant human IGF-I infusion results in transient improvement in nitrogen balance: evidence for IGF-I autoregulation. Program of the 75th Annual Meeting of The Endocrine Society, Las Vegas NV, 1993 (Abstract 1596)
13. Baxter RC, Hizuka N, Takano K, Holman SR, Asakawa K 1993 Responses of insulin-like growth factor binding protein-1 (IGFBP-I) and the IGFBP-3 complex to administration on insulin-like growth factor-I. Acta Endocrinol 128:101-108
14. Vaccarello MA, Diamond FB Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG 1993 Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency (GHRD)/Laron syndrome. J Clin Endocrinol Metab 77:273-280
15. Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KGMM, Thorner MO 1993 A Low-dose euglycemic infusion of recombinant human insulin-like growth factor-1 rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest 91:2453-2462
16. Lewitt MS, Saunders H, Cooney GJ, Baxter RC 1993 Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-1 in rats. J Endocrinol 136:253-260
17. Baxter RC, Martin JL, Beniac VA 1989 High molecular weight insulin-like growth factor binding protein complex. J Biol Chem 264:11843-11848
18. Baxter RC 1990 Circulating levels and molecular distribution of the acid-labile subunit of the high molecular weight insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 70:1347-1353
19. Guler H-P, Zapf J, Schmid C, Froesch ER 1989 Insulin-like growth factors I and II in healthy man. Estimations of half lives and production rates. Acta Endocrinol 121:753-758
20. Clemmons DR, Thissen JP, Maes M, Ketelslegers JM, Underwood LE 1989 Insulin-like growth factor-1 (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum. Endocrinology 125:2967-2972
21. Fielder PJ, Thordarson G, Talamantes F, Rosenfeld RG 1990 Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP specific serum protease activity. Endocrinology 127:2270-2280
22. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
23. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M 1986 Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of binding proteins and competitive binding studies. Anal Biochem 154: 138-143
24. Lieberman SA, Bukar J, Chen SA, Celniker AC, Compton PG, Cook J, Albu J, Perlman AJ, Hoffman AR 1992 Effects of recombinant human insulin-like growth factor-1 (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J Clin Endocrinol Metab 75:30-36
25. Baxter RC, Dai J 1994 Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology 134:848-852
26. Fielder PJ, Rosenfeld RG, Graves HCB, Grandbois K, Maack CA, Sawamura S, Ogawa Y, Sommer A, Cohen P 1994 Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3. Growth Regul 4:164-172
27. Lee CY, Rechler MW 1995 A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially. Endocrinology 136:668-678
28. Rutishauser J, Schmid C, Hauri C, Froesch ER, Zapf J 1993 Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo. FEBS Lett 334:23-26
29. Groesbeck MD, Parlow AF 1987 Highly improved precision of the hypophysectomized female rat body weight gain bioassay for growth hormone by increased frequency of injections, avoidance of antibody formation, and other simple modifications. Endocrinology 120:2582-2590
30. Schalch DS, Turman NJ, Marcsisin VS, Heffernan M, Guler H-P 1993 Short-term effects of recombinant human insulin-like- growth factor I on control of patients with type II diabetes mellitus. J Clin Endocrinol Metab 77:1563-1568
31. Underwood LE, Clemmons DR 1994 Prospects of therapy with IGF-I for catabolic conditions. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-Like Growth Factors and Their Regulatory Proteins. Excerpta Medica, Amsterdam, pp 449-456
32. Zapf J, Hauri C, Waldvogel M, Futo E, Hasler H, Binz K, Guler HP, Schmidt C, Froesch ER 1989 Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci USA 86:3813-381
33. Baxter RC, Martin JL 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78:1504-1512
34. Young SCJ, Miles MV, Clemmons DR 1992 Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats. Endocrinology 131:1867-1873
35. Lewitt MS, Saunders H, Baxter RC 1993 Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 133:1797-1802
36. Baxter RC 1994 Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140-144
37. Chin E, Zhou J, Dia J, Baxter RC, Bondy CA 1994 Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 134:2498-2504
38. Dai J, Scott CD, Baxter RC 1994 Regulation of the acid-labile subunit of insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology 135:1066-1072
39. Albiston AL, Herington AC 1992 Tissue distribution and regulation of insulin-like growth factor (IGF)-binding protein-3 messenger ribonucleic acid (mRNA) in the rat: comparison with IGF-I mRNA expression. Endocrinology 130:497-502
40. Villafuerte BC, Koop BL, Pao C-I, GU L, Birdsong GG, Phillips LS 1994 Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro. Endocrinology 134:2044-2050
41. Gargosky SE, Tapanainen P, Rosenfeld RG 1994 Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kiladalton IGF-binding protein-3 complex in GH-deficient rats. Endocrinology 134:2267-2276